ROSEN TERRY J
Chief Executive Officer
ROSEN TERRY J has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jan 26, 2026.
On the most recent filing, ROSEN TERRY J is listed as Chief Executive Officer at Arcus Biosciences, Inc. Inside the rolling window, ROSEN TERRY J reported no open-market purchases and 2 open-market sales totaling $1.2M in RCUS. The largest disclosed transaction in the window is a sale of 28,947 RCUS shares on Dec 16, 2025, worth $633K.
Companies traded
Other insiders at RCUS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ROSEN TERRY J made?
ROSEN TERRY J has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does ROSEN TERRY J trade?
ROSEN TERRY J has filed SEC Form 4 disclosures for 1 company, including RCUS.
When was ROSEN TERRY J's most recent SEC Form 4 filing?
ROSEN TERRY J's most recent SEC Form 4 filing on Tracefour is dated Jan 26, 2026.
What is ROSEN TERRY J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ROSEN TERRY J is listed as Chief Executive Officer.
What is ROSEN TERRY J's total buy and sell value in the current window?
Inside the rolling retention window, ROSEN TERRY J bought $0 and sold $1.2M based on SEC Form 4 filings.
What was ROSEN TERRY J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 28,947 RCUS shares on 2025-12-16, worth $633K, per SEC Form 4 filings.